Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States-Reference-Cited by-同舟云学术

Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States

Published:2020-10-05 Issue:2 Volume:30 Page:126-134
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Liu Wei¹^ORCID,Menzin Talia J.²,Woods Corinne M.¹^ORCID,Haug Nicole R.²,Li Jie¹,Mathew Justin A.¹,Nguyen Christine P.³,Chai Grace P.¹,Moeny David G.¹,Shinde Mayura²

Affiliation:

1. Division of Epidemiology Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA

2. Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care Institute Boston Massachusetts USA

3. Division of Bone, Reproductive, and Urologic Products Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5112

Reference27 articles.

1. ACOG practice bulletin no. 204: fetal growth restriction;Gynecologists ACoOa;Obstet Gynecol,2019

2. Early‐onset fetal growth restriction: A systematic review on mortality and morbidity

3. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction

4. Early‐onset fetal growth restriction treated with the long‐acting phosphodiesterase‐5 inhibitor tadalafil: a case report;Sakamoto M;J Med Case Rep,2016

5. Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS);Molecular and Cellular Biochemistry;2023-07-03

2. The US Food and Drug Administration Sentinel System: a national resource for a learning health system;Journal of the American Medical Informatics Association;2022-09-12

3. Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations;International Journal of Environmental Research and Public Health;2022-09-06

4. Prescription medication use and baseline health status of women with live-birth deliveries in a national data network;American Journal of Obstetrics & Gynecology MFM;2022-01

5. Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia;Acta Obstetricia et Gynecologica Scandinavica;2021-08-28